Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 1Motor Activity 1Esophageal Neoplasms 1

Interventions

pembrolizumab 16Bevacizumab 11Carboplatin 10Nivolumab 8Pemetrexed 7Temozolomide 6atezolizumab 5Standard of Care 5Prednisone 5Exercise 5Cyclophosphamide 5Cetuximab 5durvalumab 4abemaciclib 4Paclitaxel 4Dexamethasone 4Cisplatin 4Blood Specimen Collection 4dostarlimab 3daratumumab 3cabozantinib 3Rituximab 3Oxaliplatin 3Metformin 3Leucovorin 3Lenalidomide 3Ipilimumab 3Fluorouracil 3Doxorubicin 3Docetaxel 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Nutritional Status × 30 days × Clear all
NCT05912257 2026-05-20

NOSH

VA Office of Research and Development

Phase NA Recruiting
188 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡